Latest updates for Amavex

Fresh curated links around Amavex are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • ADVX Expands Medical Business Consulting Services in Melbourne
  • <![CDATA[Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]>
  • <![CDATA[Novartis & BoomRay Enter Global License Agreement for Preclinical Radioligand Asset]]>

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

qchron.com /1 month ago

ADVX Expands Medical Business Consulting Services in Melbourne

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Roundup: AbbVie &amp; Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]&gt;

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Novartis &amp; BoomRay Enter Global License Agreement for Preclinical Radioligand Asset]]&gt;

Read source
newswire.com /1 day ago

DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network

Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026Program will aim...

Read source
seekingalpha.com /1 month ago

Axsome rises on Auvelity prescription data

Read source
cafepharma.com /5 days ago

Argenx

Argenx Anonymous (not verified) Mon, 10/19/2026 - 10:14 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source
cafepharma.com /3 days ago

Averitas

Averitas Anonymous (not verified) Wed, 10/21/2026 - 13:15 field_thread_url https://cafepharma.com/boards/threads/averitas.667825/ board...

Read source
newswire.com /2 weeks ago

NexTel Medical Corp. Announces Next-Generation Wellness Product Line Incorporating FDA-Approved Pharmaceuticals

Innovative Delivery Technologies Aimed at Enhancing Bioavailability and Expanding Patient Access Beyond Traditional Injections

Read source
cafepharma.com /1 month ago

BioXcel

BioXcel Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/bioxcel.674502/ board na...

Read source
qchron.com /2 weeks ago

AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm

NEW YORK, Oct. 5, 2026 /PRNewswire/ --

Read source
qchron.com /3 weeks ago

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential...

Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager

Read source
law360.com /4 days ago

Genentech, Novartis Sue Amneal Over Bid To Sell Xolair Copy

Genentech Inc. and Novartis Pharmaceuticals Corp. have filed a patent infringement suit in Delaware federal court, claiming Kashiv BioSciences' bid to sell a biosimilar copy of the...

Read source
newswire.com /4 weeks ago

NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference

Company highlights ongoing clinical developments in traumatic brain injury (TBI) therapeutics and non-invasive cancer screening, sparking key vendor collaboration discussions.

Read source
pharmexec.com /4 weeks ago

&lt;![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Roundup: Alteogen Enters Option &amp; License Agreement with Novartis, NewBiologix &amp; Synastra Form BioTe...

Read source
newswire.com /1 month ago

Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development

Company Making Critical Progress in Scalable Manufacturing and Preparing the Lead Trispecific Candidate for Future Human TestingTrispecifics Combine Three Complementary Cancer-Figh...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[M&amp;A Roundup: DualityBio &amp; Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Read source
cafepharma.com /3 weeks ago

Revolution Medicines

Revolution Medicines Anonymous (not verified) Wed, 09/30/2026 - 01:04 field_thread_url https://cafepharma.com/boards/threads/revolution-medicines.709803/...

Read source
pharmexec.com /1 month ago

&lt;![CDATA[Osivax And GC Biopharma Enter Collaboration to Develop Next Generation Influenza Vaccine ]]&gt;

Read source
fool.com /1 month ago

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.

Read source
law360.com /1 week ago

Mayne Settles US Patent Suit With Teva Over Generic Imvexxy

ASX-listed Mayne Pharma announced on Friday another settlement related to its oestradiol vaginal insert Imvexxy, with medicines maker Teva Pharmaceuticals USA Inc. agreeing not to...

Read source
newswire.com /1 month ago

Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results

Fourth quarter fiscal 2026 net revenue increased 6.4% to $16.1 million from $15.1 million in the prior-year quarterFourth quarter fiscal 2026 Adjusted EBITDA of $0.5 millionEXXUA n...

Read source
pharmexec.com /2 days ago

&lt;![CDATA[Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreeme...

Read source
cafepharma.com /1 month ago

Axogen

Axogen Anonymous (not verified) Mon, 09/14/2026 - 18:53 field_thread_url https://cafepharma.com/boards/threads/axogen.530270/ board name...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Amavex

cafepharma.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

law360.com

Recent coverage from public sources
Public source

newswire.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source